Last updated 2026-06-18
- Raised funding round, May 2017
Total raised
—
Last: 2017-05
Stage
Seed
Founded
2014
Headcount
6
HQ
, Israel
Sector
Health Tech & Life Sciences
About
HepaRx is developing a small molecule cancer drug that inhibits heparanase (Hpa) enzymatic activity in order to stop the spread of cancer cells. The company is employing the Hpa crystal structure for drug design and development. Hpa has been evaluated extensively as a target for drug development, showing substantial involvement in disease progression and high-level expression in various cancer types including pancreatic, lung, breast, and mesothelioma. HepaRx has been operating in the framework of the biotech accelerator FutuRx.
Funding history · 1 round · — total
2017-05
Undisclosed
Q&A
- What is HepaRx's primary focus?
- HepaRx is developing a small molecule cancer drug designed to inhibit heparanase (Hpa) enzymatic activity to prevent the spread of cancer cells.
- When was HepaRx founded?
- HepaRx was founded in September 2014.
- What is the current status of HepaRx?
- HepaRx is currently inactive and ceased to operate in July 2018.
- Which accelerator has HepaRx operated within?
- HepaRx has operated within the framework of the biotech accelerator FutuRx.
- What is HepaRx's employee count?
- HepaRx has an employee count in the 1-10 range.
- Who is the CEO of HepaRx?
- Dr. Nili Schutz is the CEO of HepaRx.
- Who is listed as an inventor for HepaRx?
- Prof. Israel Vlodavsky is listed as an inventor for HepaRx.
- What is the primary sector classification for HepaRx?
- HepaRx's primary sector classification is Health Tech & Life Sciences.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
oncologydrug-designpharma-companiesbiopharmaceutical
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2014-9 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Jul 2018 ceased to operate |